Clinical / R & D
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Clinical Trials
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
![](/-/media/editorial/products/b/biolinq_sensor_1200.png?rev=a03e95a840684e23a48ad7c43eb26de5&w=350&hash=BC7C26E36DDD0C91AD7C316CCD0E439A)
Biolinq Aims To Transform Diabetic Glucose Monitoring With Needle-Free Patch
Biolinq’s CEO Rich Yang spoke to Medtech Insight about the company’s wearable patch in development, which uses tiny microsensors to measure, for now, glucose, with ample runway for additional indications down the line. If approved by the US FDA, the device would become the first of its kind to monitor glucose levels in diabetes patients not using insulin.
![](/-/media/editorial/medtech-insight/2024/07/mti_0718204_investing.jpg?rev=227e35b4cf2543e59b1346decff9faa1&w=350&hash=09B14FF8B4BFD2BB3ABD1FEF90596CCD)
Truvian Health Raises $74M In Funding For Automated Benchtop Blood Testing Analyzer, Pursues FDA Clearance
Truvian Health said it raised $74m in venture capital funding, which the company plans to use in part to try to secure US FDA clearance for its blood testing platform.
![](/-/media/editorial/medtech-insight/2024/07/mti-opioidepidemic-1200.jpg?rev=39e2c059d95542c59c080effd9d4bc4f&w=350&hash=AA858A20ADAEAEFF6C028FB8F90B97B7)
FDA Drops Final Guidance On Devices Designed To Treat Opioid Abuse
The FDA has published final guidance to assist developers of medical devices designed to treat opioid use disorder, along with considerations for sponsors of clinical studies to evaluate those devices.
![](/-/media/editorial/medtech-insight/2021/10/mt2110_congress_money_1200_2ea2wra.jpg?rev=c3e93426c89c4f1f9aa5775e664d3c09&w=350&hash=C8750AB93401A271623AD030B9062601)
FDA's LDT Overhaul Should Go Back To Congress, Appropriations Report Says
A fiscal 2025 report from the US House Appropriations Committee instructs the FDA to halt implementation of its overhaul of LDT regulation. Members also showed concern about overseas device manufacturing and the availability of over-the-counter diagnostics.
New Technology
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
![](/-/media/editorial/products/b/biolinq_sensor_1200.png?rev=a03e95a840684e23a48ad7c43eb26de5&w=350&hash=BC7C26E36DDD0C91AD7C316CCD0E439A)
Biolinq Aims To Transform Diabetic Glucose Monitoring With Needle-Free Patch
Biolinq’s CEO Rich Yang spoke to Medtech Insight about the company’s wearable patch in development, which uses tiny microsensors to measure, for now, glucose, with ample runway for additional indications down the line. If approved by the US FDA, the device would become the first of its kind to monitor glucose levels in diabetes patients not using insulin.
![](/-/media/editorial/medtech-insight/2024/07/mt2407_tricares-topaz_1200.jpg?rev=3f5d568ae4ed45739cdb2fc5e0633027&w=350&hash=8C522BB075FA486F8912A3311416FF3E)
TRiCares Secures $50M For Tricuspid Replacement System, Topaz
TRiCares SAS announced it raised $50m in series D funding from a single unnamed investor. The funding will support the company’s upcoming US early feasibility study and EU CE mark clinical investigation for its transfemoral tricuspid heart valve replacement system, Topaz.
![](/-/media/editorial/medtech-insight/2024/07/mt2407_cardiology_shutterstock_231314745_1200.jpg?rev=cf58377738fe443599bca2ca0e2524d5&w=350&hash=CE419412A1C881CFFC2AC20C39E6EB6F)
Magenta Medical Secures $105M To Advance ‘World's Smallest Heart Pump’
Magenta Medical is preparing to launch a pivotal trial for its Elevate percutaneous Left Ventricular Assist Device, armed with $105m in new funding announced on 23 July. The company’s minimally invasive, FDA-designated Breakthrough Device supports heart function during high-risk percutaneous coronary intervention procedures.
![](/-/media/editorial/medtech-insight/00_regular-column-images/digitalhealth_roundup_1200.jpg?rev=a3b924ac74fd4f05bfde9e19f9c66ea6&w=350&hash=6F97547DA91630A66164D33237DA1370)
Digital Health Roundup: Brain Talk On Seizures, Alzheimer's, Stress, Anxiety; Medtronic's OR Report; Health Care AI; UK Guidances
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights AI discussions at the HLTH Europe conference and an interview with Motif Neurotech's CEO Jacob Robinson. Elizabeth Orr discusses DeepWell DTx's newly launched VR game for treating stress-related hypertension and anxiety. Natasha Barrow provides an overview of Digital Mental Health Technologies regulation in the UK and Brian Bossetta reports ‘the good and bad’ from Medtronic's report on digital technologies' use in the operating room.
Approvals
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
![](/-/media/editorial/medtech-insight/00_regular-column-images/digitalhealth_roundup_1200.jpg?rev=a3b924ac74fd4f05bfde9e19f9c66ea6&w=350&hash=6F97547DA91630A66164D33237DA1370)
Digital Health Roundup: Brain Talk On Seizures, Alzheimer's, Stress, Anxiety; Medtronic's OR Report; Health Care AI; UK Guidances
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights AI discussions at the HLTH Europe conference and an interview with Motif Neurotech's CEO Jacob Robinson. Elizabeth Orr discusses DeepWell DTx's newly launched VR game for treating stress-related hypertension and anxiety. Natasha Barrow provides an overview of Digital Mental Health Technologies regulation in the UK and Brian Bossetta reports ‘the good and bad’ from Medtronic's report on digital technologies' use in the operating room.
![](/-/media/editorial/medtech-insight/00_regular-column-images/mti2301_newswerewatching_1200.png?rev=688714c023c14838b737c7a06cd71521&w=350&hash=96B7B2D80A4AD95988467585BE50FE74)
News We’re Watching: Nipro Medical Invests $397.8M In First US Facility; Baxter, Hamilton Ventilator Recalls; FDA Warnings; And More
This week, Nipro Medical Corp. announced it will invest $397.8m to build a US-based production plant, generating 232 new jobs; both Baxter and Hamilton announced ventilator recalls; Imperative Care wins FDA clearance for its stroke catheter; Intelligent Ultrasound Group plc entered into a conditional sale and purchase deal to sell its Clinical AI business to GE HealthCare for £40.5m; RMI distributed 350m rapid test kits in the fight against HIV/AIDS; Jiangsu Shenli Medical Production Co., Ltd received a second FDA warning letter about quality and safety of plastic syringes.
![](/-/media/editorial/medtech-insight/00_regular-column-images/mti2301_newswerewatching_1200.png?rev=688714c023c14838b737c7a06cd71521&w=350&hash=96B7B2D80A4AD95988467585BE50FE74)
News We’re Watching: FDA Issues Monkeypox EUAs, IMDRF Publishes AI Principes, Quest Buys LifeLabs
This week, the US FDA authorized EUAs for at-home mpox tests and announced a public workshop on implanted brain devices; the IMDRF published guiding principles on good machine learning practices for AI; and Quest announced its deal to acquire a Canadian diagnostic firm.
![](/-/media/editorial/medtech-insight/2024/06/mti2406_orthopedic_1926790544_1200.jpg?rev=7ef5750f79c54a8bb00b440110c5e700&w=350&hash=F5BC6DA93098436C2E2FA033E1C79A54)
Pediatric Orthopedic Device Drought Continues, Study Finds
A recent review of orthopedic device approvals between 2018 and 2022 found that less than 10% of 510(k) devices – and less than 5% of PMA and de novo products – have been authorized for use in children, highlighting the ongoing lack of pediatric devices.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.